دوره 6، شماره 2 - ( 9-1398 )
جلد 6 شماره 2 صفحات 13-9 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mirzaei B, Haghshenas M R, Goli H, Babaei R. Putative Targets as Vaccine Candidates with Respect to Biofilm Formation Procedure in Staphylococci. vacres 2019; 6 (2) :9-13
URL: http://vacres.pasteur.ac.ir/article-1-174-fa.html
URL: http://vacres.pasteur.ac.ir/article-1-174-fa.html
Putative Targets as Vaccine Candidates with Respect to Biofilm Formation Procedure in Staphylococci. Vaccine Research. 1398; 6 (2) :9-13
چکیده: (3126 مشاهده)
The amount of multidrug-resistant (MDR) strains, especially methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis, as frequent causes of nosocomial and device-related infections have increased. Biofilm formation is an essential requisite in staphylococcal pathogenicity. It is considered as a bacterial surveillance, antibiotic resistance, and transition of antibiotic resistance genes factor. Therefore, biofilm-related macromolecules have been suggested as putative new vaccine candidates to combat staphylococcal infections. Based on the MEDLINE and Google scholar databases, some Staphylococci macromolecules are involved in the biofilm formation process and have been reviewed as putative vaccines. Based on experiments, common staphylococcus antigens could prevent the progress of the caused diseases by this genus. Moreover, considering related stages in biofilm formation, a multivalent putative vaccine (protein and polysaccharide) candidate could be enhancing the eradication chance of aforementioned bacterial families.
نوع مطالعه: Review article |
موضوع مقاله:
Vaccine development, efficacy and safety evaluation
دریافت: 1398/12/6
دریافت: 1398/12/6
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.